You just read:

Research and Markets - Pulmonary Arterial Hypertension Therapeutics Market, 2022 - Global Strategic Business Report 2017: Key Players are Actelion, Bayer, Gilead Sciences, Pfizer, United Therapeutics & Lung Biotechnology PBC

News provided by

Research and Markets

06 Mar, 2017, 12:00 ET